Cybin highlights 2024 accomplishments and upcoming milestones for 2025

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to provide a year-end summary of its key accomplishments in 2024 and upcoming milestones for 2025. “in 2024, we made significant progress toward our goal of transforming the mental health treatment landscape,” said dou.
CYBN Ratings Summary
CYBN Quant Ranking